Opportunity Information: Apply for RFA AI 21 023

The Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) funding opportunity (RFA-AI-21-023) is a National Institutes of Health (NIH) R01 grant designed to strengthen the "RESPOND" pillar of the federal Ending the HIV Epidemic: A Plan for America (EHE) initiative. Its core focus is on practical, action-oriented epidemiology that helps communities and public health systems better understand who remains vulnerable to HIV, where and how transmission is still occurring, and what local conditions are driving those patterns. The overall intent is to generate timely, decision-ready evidence that can shape interventions and allow faster, more context-specific evaluation of HIV control strategies, with the broader national goal of ending the HIV epidemic in the United States.

This FOA prioritizes research that uses local and population-level epidemiologic approaches and is carried out in collaboration with implementing partners. In plain terms, it is not just about producing academic findings; it is about working alongside organizations that actually deliver services or implement prevention and treatment programs so that the data collected can directly inform real-world action. Projects supported under this announcement are expected to improve understanding of HIV susceptibility and ongoing transmission in U.S. settings, which can include geographic "hot spots," specific populations disproportionately affected by HIV, or systems-level factors that make prevention and care less effective. By emphasizing local epidemiology and partnerships, the program is aiming for results that are relevant to the specific communities where HIV transmission persists and where EHE efforts need the most precise guidance.

The award mechanism is an NIH R01, and the FOA notes that clinical trials are optional, meaning applicants can propose studies with or without a clinical trial component as long as the work aligns with the epidemiology-to-action intent of the program. The funding opportunity is categorized as discretionary and is listed under health and education activity categories. It is associated with CFDA numbers 93.242, 93.279, and 93.855, reflecting its placement within NIH public health research portfolios.

Eligibility is broad and includes a wide range of U.S.-based entities capable of conducting research and partnering with public health implementers. Eligible applicants include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; small businesses; and other organizations that meet NIH eligibility rules. The FOA also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions. This emphasis signals an intent to bring in institutions and organizations closely connected to communities most affected by HIV and to support place-based, equity-centered research capacity.

At the same time, the FOA draws clear boundaries around foreign involvement. Non-domestic (non-U.S.) entities (foreign organizations and foreign institutions) are not eligible to apply. In addition, non-domestic components of U.S. organizations are not eligible, and foreign components as defined in the NIH Grants Policy Statement are not allowed. In practice, this means the work must be fully grounded within the United States and its territories, and applicants cannot rely on foreign institutional partners to carry out project components that NIH would classify as foreign.

The opportunity was created on March 30, 2021, with an original closing date of July 30, 2021. While the summary information provided does not specify an award ceiling or the expected number of awards, the main takeaway is that this is a targeted NIH research investment intended to make HIV epidemiology more immediately useful for program implementation under EHE. The expected impact is better, faster insight into ongoing HIV transmission dynamics and susceptibility in U.S. communities, leading to better-targeted interventions and more rapid assessment of whether those interventions are working in the specific contexts where they are deployed.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Respond: Epidemiology to End the HIV Epidemic (RESPOND: EEE) (R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242, 93.279, 93.855.
  • This funding opportunity was created on 2021-03-30.
  • Applicants must submit their applications by 2021-07-30. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA AI 21 023

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Central Asia Design Hub

Previous opportunity: AK-21-01: Winter Ringed Seal Density within Beaufort Sea Oil and Gas Project Areas

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AI 21 023

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AI 21 023) also looked into and applied for these:

Funding Opportunity
Prevention Strategies to End the HIV Epidemic (R01 Clinical Trial Optional) Apply for RFA AI 21 025

Funding Number: RFA AI 21 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Multidisciplinary Treatment Approaches to End the HIV Epidemic (R01 Clinical Trial Optional) Apply for RFA AI 21 024

Funding Number: RFA AI 21 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Limited Competition Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) Apply for RFA DA 22 002

Funding Number: RFA DA 22 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) Apply for PAR 21 213

Funding Number: PAR 21 213
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $500,000
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R43/R44 - Clinical Trial Not Allowed) Apply for RFA DA 22 019

Funding Number: RFA DA 22 019
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Leveraging Artificial Intelligence (AI) tools for Substance Use Disorders (SUD) drug discovery and development (R41/R42 - Clinical Trial Not Allowed) Apply for RFA DA 22 021

Funding Number: RFA DA 22 021
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Centers on Telehealth Research for Cancer-Related Care (P50 Clinical Trial Required) Apply for RFA CA 21 029

Funding Number: RFA CA 21 029
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mobile Health Solutions to rectify digital inequality in communities affected by drug addiction (R43/R44 Clinical Trial Optional) Apply for RFA DA 22 001

Funding Number: RFA DA 22 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exercise and Nutrition Interventions to Improve Cancer Treatment-Related Outcomes (ENICTO) in Cancer Survivors Consortium (U01 Clinical Trial Required) Apply for RFA CA 21 031

Funding Number: RFA CA 21 031
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $875,000
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional) Apply for PA 21 180

Funding Number: PA 21 180
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Clinical Trial Not Allowed) Apply for RFA DA 22 007

Funding Number: RFA DA 22 007
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanistic studies on the impact of social inequality on the substance use trajectory (R21 - Clinical Trial Not Allowed) Apply for RFA DA 22 005

Funding Number: RFA DA 22 005
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R01 Basic Experimental Studies with Humans Required) Apply for RFA DA 22 024

Funding Number: RFA DA 22 024
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanistic Studies on the Impact of Social Inequality on the Substance Use Trajectory (R21 - Basic Experimental Studies with Humans Required) Apply for RFA DA 22 030

Funding Number: RFA DA 22 030
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Assessing the Effects of Cannabinoids on HIV-Associated Persistent Inflammation (R01 Clinical Trial Optional) Apply for RFA DA 22 012

Funding Number: RFA DA 22 012
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The Early Detection Research Network: Clinical Validation Centers (U01 Clinical Trial Optional) Apply for RFA CA 21 033

Funding Number: RFA CA 21 033
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The Early Detection Research Network: Data Management and Coordinating Center (U24 Clinical Trial Not Allowed) Apply for RFA CA 21 034

Funding Number: RFA CA 21 034
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
The Early Detection Research Network: Biomarker Characterization Centers (U2C Clinical Trial Not Allowed) Apply for RFA CA 21 035

Funding Number: RFA CA 21 035
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 Clinical Trial Optional) Apply for PAR 21 138

Funding Number: PAR 21 138
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Exploratory Studies to Investigate the Mechanisms of Interrelationship Between Sleep and Substance Use Disorders (R61/R33 Clinical Trials Not Allowed) Apply for RFA DA 22 016

Funding Number: RFA DA 22 016
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 21 023", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: